Phase II trial compares IMCgp100 vs investigator choice in advanced uveal melanoma
Can a new drug help people with a rare eye cancer live longer?
This Phase II study evaluated IMCgp100 versus investigator's choice (dacarbazine, ipilimumab, or pembrolizumab) in HLA-A*0201 positive adult…
A new drug for advanced eye cancer is being compared to standard treatments to see if it helps patients with a specific genetic marker live …
Phase 3 trial of bimekizumab versus placebo in 435 adults with moderate to severe plaque psoriasis
Can a new drug help people with moderate to severe plaque psoriasis?
A phase 3 randomized controlled trial evaluated bimekizumab versus placebo in 435 adults with moderate to severe chronic plaque psoriasis. T…
A new drug tested in a large study aims to help clear skin for people with moderate to severe plaque psoriasis.
Phase 3 Study Evaluates Barzolvolimab for Chronic Spontaneous Urticaria
Can a new treatment finally help those suffering from chronic hives?
A Phase 3 trial assesses barzolvolimab's efficacy and safety in CSU patients unresponsive to antihistamines.
Adults with chronic hives who don't get relief from standard antihistamines may find new hope in a new treatment called barzolvolimab being …
Sliding Cupping Therapy Matches NBUVB in Psoriasis Severity Reduction at 8 Weeks
Could Sliding Cupping Therapy Be a Game-Changer for Psoriasis Patients?
In a RCT with 60 psoriasis patients, sliding cupping showed similar efficacy to NBUVB in reducing PASI scores by 62.4% vs. 66.9% (P=.526).
Sliding cupping therapy improved psoriasis symptoms just as well as standard light treatment, offering a viable alternative for patients see…